Emerging trends in the use of drugs to manage the challenging behaviour of people with intellectual disability

Journal of Applied Research in Intellectual Disabilities

Volumn 19, Issue 2, 2006, Pages 163-172

  McGillivray, Jane A ^a   McCabe, Marita P ^a  

^a DEAKIN UNIVERSITY   (Australia)

Author keywords

Challenging behaviour; Drug changes over time; Intellectual disability; Pharmacological management

Indexed keywords

EID: 33646727436     PISSN: 13602322     EISSN: 14683148     Source Type: Journal    
DOI: 10.1111/j.1468-3148.2005.00251.x     Document Type: Article

References (47)

1. Aman M. G. (1984) Drugs and learning in mentally retarded persons. In: Advances in Human Psychopharmacology, Vol. 3 (eds G. D. Burrows & J. S. Werry), pp. 121-163. JAI Press, Greenwich, CT.
2. Arnold L. E., Gadow K., Pearson D. & Varley C. K. (1998) Stimulants. In: Psychotropic Medication and Developmental Disabilities: The International Consensus Handbook (eds S. Reiss & M. G. Aman), pp. 229-257. Ohio State University, Columbus, OH.
3. Baumeister A. A. & Sevin J. A. (1990) Pharmacologic control of aberrant behavior in the mentally retarded: toward a more rational approach. Neuroscience and Biobehavioral Reviews 14, 252-262.
4. Baumeister A. A., Sevin J. A. & King B. H. (1998) Neuroleptic medications. In: Psychotropic Medications and Developmental Disabilities: The International Consensus Handbook (eds S. Reiss & M. G. Aman), pp. 133-150. Ohio State University, Columbus, OH.
5. Bodfish J. W. & Madison J. (1993) Diagnosis and fluoxetine treatment of compulsive behaviour disorder of adults with mental retardation. American Journal on Mental Retardation 98, 360-367.
6. Boshes R. A. (1987) Pharmacotherapy for patients with mental retardation and mental illness. Psychiatric Annals 17, 627-632.
7. Brylewski J. & Duggan L. (1999) Antipsychotic medication for challenging behaviour in people with intellectual disability: a systematic review of randomized controlled trials. Journal of Intellectual Disability Research 43, 360-371.
8. Charlot L. R. (1997) Irritability, aggression, and depression in adults with mental retardation: a developmental perspective. Psychiatric Annals 27, 190-197.
9. Charlot L. R., Doucette A. C. & Mezzacappa E. (1993) Affective symptoms of institutionalized adults with mental retardation. American Journal on Mental Retardation 98, 408-416.
10. Cooper S. A. & Collacott R. A. (1996) Depression in adults with learning disabilities: a critical review. Irish Journal of Psychological Medicine 13, 105-113.
11. Craig T. J. & Bracken J. (1995) An epidemiologic study of p.r.n./stat. medication use in a state psychiatric hospital. Annals of Clinical Psychiatry 7, 57-64.
12. Didden R., Duker R. & Korzilius H. (1997) Meta-analytic study on treatment effectiveness for problem behaviours with individuals who have mental retardation. American Journal of Mental Retardation 101, 387-399.
13. Emerson E., Moss S. C. & Kiernan C. K. (1999) The relationship between challenging behaviour and psychiatric disorders in people with severe intellectual disabilities. In: Psychiatric and Behavioural Disorders in Developmental Disabilities and Mental Retardation (ed. N. Bouras), pp. 38-48. Cambridge University Press, Cambridge.
14. Fava M., Rankin M. A., Wright E. C., Alpert J. E., Nierenberg A. A., Pava J. & Rosenbaum J. F. (2000) Anxiety disorders in major depression. Comprehensive Psychiatry 41, 97-102.
15. Fox R. A. & Wade E. J. (1998) Attention deficit hyperactivity disorder among adults with severe and profound mental retardation. Research in Developmental Disabilities 19, 275-280.
16. Griez E. & Overbeek T. (1997) Comorbidity of depression and anxiety. In: Depression: Neurobiological, Psychopathological and Therapeutic Advances. Wiley Series on Clinical and Neurobiological Advances in Psychiatry, Vol. 3. (eds A. Honig & H. M. Praag), pp. 41-57. John Wiley and Sons, New York.
17. Holden B. & Gitlesen J. P. (2003) Prevalence of psychiatric symptoms in adults with mental retardation and challenging behaviour. Research in Developmental Disabilities 24, 323-332.
18. Intellectually Disabled Persons Services Act (1986) Act No. 53/1986. Victoria Government Printer, Melbourne.
19. Jenkins R., Rose J. & Jones T. (1998) The checklist of challenging behavior and its relationship with the Psychopathology Inventory for Mentally Retarded Adults, Journal of Intellectual Disability Research 42, 273-278.
20. Kalachnik J. E., Levethal B. L., James D. H., Sovner R., Kastner T. A., Walsh K., Weisblatt S. A. & Klitzke M. G. (1998) Guidelines for the use of pschotropic medication. In: Psychotropic Medication and Developmental Disabilities: The International Consensus Handbook (eds S. Reiss & M. G. Aman), pp. 45-71. Ohio State University, Columbus, OH.
21. Lowry M. A. & Sovner R. (1992) Severe behavior problems associated with rapid cycling bipolar disorder in two adults with profound mental retardation. Journal of Intellectual Disabilities Research 36, 269-281.
22. Luiselli J. K., Blew P. & Thibadeau S. (2001) Therapeutic effects and long term efficacy of antidepressant medication for persons with developmental disabilities. Behavior Modification 25, 62-71.
23. Lunsky Y. (2003) Depressive symptoms in intellectual disability: does gender play a role? Journal of Intellectual Disability Research 47, 417-427.
24. Marston G. M., Perry D. W. & Roy A. (1997) Manifestations of depression in people with intellectual disability. Journal of Intellectual Disability Research 41, 476-480.
25. Matson J. L., Bamburg J. W., Mayville E. A., Pinkston J., Bielecki J., Kuhn D., Smalls Y. & Logan J. R. (2000) Psychopharmacology and mental retardation: A 10 year review (1990-1999). Research in Developmental Disabilities 21, 263-296.
26. Matson J. L., Bielecki J., Mayville S. B. & Matson M. L. (2003) Psychopharmacology research for individuals with mental retardation: methodological issues and suggestions. Research in Developmental Disabilities 24, 149-157.
27. McGillivray J. A. & McCabe M. P. (2004) Pharmacological management of challenging behavior of individuals with intellectual disability. Research in Developmental Disabilities 25, 523-537.
28. McManus P., Mant A., Mitchell P. B., Montgomery W. S., Marley J. & Auland M. E. (2000) Recent trends in the use of antidepressant drugs in Australia, 1990-1998. Medical Journal of Australia 173, 458-461.
29. Meins W. (1993) Assessment of depression in mentally retarded adults: Reliability and validity of the Children's Depression Inventory (CDI). Research in Developmental Disabilities 14, 299-312.
30. Meins W. (1995) Symptoms of major depression in mentally retarded adults. Journal of Intellectual Disability Research 39, 41-45.
31. Mikkelsen E. J., Albert L. G., Emens M. & Rubin E. (1997) The efficacy of antidepressant medication for individuals with mental retardation. Psychiatric Annals 27, 198-206.
32. MIMS Australia (2001) MIMS Annual 23rd edn. MIMS Australia, Crows Nest, NSW, Australia.
33. Moss S., Emerson E., Kiernan C., Turner S., Hatton C. & Alborz A. (2000) Psychiatric symptoms in adults with learning disability and challenging behaviour. British Journal of Psychiatry 177, 452-456.
34. Parker G., Wilhelm K. & Asghari A. (1997) Early onset depression: the relevance of anxiety. Social Psychiatry and Psychiatric Epidemiology 32, 30-37.
35. Pearson D. A., Yaffee L. S., Loveland K. A. & Lewis K. R. (1996) Comparison of sustained and selective attention in children who have mental retardation with and without attention deficit hyperactivity disorder. American Journal on Mental Retardation 100, 592-607.
36. Reiss S. & Aman M. G. (eds) (1998) Psychotropic Medications and Developmental Disabilities: The International Consensus Handbook. The Ohio State University Nisonger Center, Columbus, OH.
37. Reiss S. & Rojahn J. (1993) Joint occurrence of depression and aggression in children and adults with mental retardation. Journal of Intellectual Disability Research 37, 287-294.
38. Rey J. M., Walter G. & Hazell P. (2000) Psychotropic drugs and preschoolers. Medical Journal of Australia 173, 172-173.
39. Rinck C. & Calkins C. F. (1989) Patterns of psychotropic medication use among older persons with developmental disabilities, Journal of Applied Gerontology 8, 216-227.
40. Sawyer M. G., Rey J. M., Graetz B. W., Clark J. & Badhurst P. A. (2002) Use of medication by young people with attention-deficit/hyperactivity disorder. Medical Journal of Australia 177, 21-25.
41. Singh N. N., Ellis C. R. & Wechsler H. (1997) Psychopharmacoepidemiology of mental retardation: 1966 to 1995. Journal of Child and Adolescent Psychopharmacology 7, 255-266.
42. Sommi R. W., Benefield W. H., Curtis J. L., Lott R. S., Saklad J. J. & Wilson J. (1998) Drug interactions with psychotropic medications. In: Psychotropic Medication and Developmental Disabilities: The International Consensus Handbook (eds S. Reiss & M. G. Aman), pp. 115-131. Ohio State University, Columbus, OH.
43. Sturmey P. (1995) Diagnositic-based pharmacological treatment of behavior disorders in persons with developmental disabilities: a review and a decision-making typology. Research in Developmental Disabilities 16, 235-252.
44. Suresh T. (1998) 'As required' neuroleptics: Have these drugs a place in the management of challenging behaviours in intellectual disability? Journal of Intellectual Disability Research 42, 500-504.
45. Tsiouris J. A., Mann R., Parti P. J. & Sturmey P. (2003) Challenging behaviours should not be considered as depressive equivalents in individuals with intellectual disability. Journal of Intellectual Disability Research 47, 14-21.
46. Victorian Department of Human Services, DisAbility Services Branch (2001) Restraint and Seclusion Policy, Victorian Department of Human Services, DisAbility Services Branch, Melbourne.
47. Wolraich M. (2001) Increased psychotropic medication use: are we improving mental health care or drugging our kids? (editorial). Archives of Pediatric Adolescent Medicine 155, 545.